{"url_path":"/sec/crbu/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1619856/0001619856-26-000043-index.html","accession_number":"0001619856-26-000043","cik":"0001619856","ticker":"CRBU","issuer_name":"Caribou Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1619856/0001619856-26-000043-index.html","primary_entity_key":"0001619856","primary_entity_name":"Caribou Biosciences, Inc."},"word_count":96,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.Description\n\n99.1\n[Press Release Issued by Caribou Biosciences, Inc. on June 11, 2026](crbu-20260611xexx991.htm)\n\n99.2\n[Press Release Issued by Caribou Biosciences, Inc. on June 11, 2026](crbu-20260611xexx992.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nCaribou Biosciences, Inc.\n\nDate:June 11, 2026By:\n /s/ Rachel E. Haurwitz\n\nRachel E. Haurwitz\n\nPresident and Chief Executive Officer"}